NIFTY 50▲24,648.45
242.35 (0.99%)
SENSEX▲80,709.46
669.66 (0.84%)
NIFTY BANK▲50,903.60
14.85 (0.03%)
INDIAN RAILWAY FINANCE CORP▲184.58
1.02 (0.56%)
TATA MOTORS▲1,098.10
7.15 (0.66%)
TATA STEEL▲162.49
5.10 (3.24%)
TATA POWER▲439.35
16.00 (3.78%)
SUZLON ENERGY▲62.60
1.13 (1.84%)
RAIL VIKAS NIGAM▼561.90
-13.80 (-2.40%)
INDIAN RENEWABLE ENERGY▲262.75
1.57 (0.60%)
VODAFONE IDEA▲15.97
0.79 (5.20%)
RELIANCE INDUSTRIES▲3,005.95
21.15 (0.71%)
YES BANK▲25.09
0.47 (1.91%)
ADANI POWER▲713.00
17.80 (2.56%)
NHPC▲104.96
3.00 (2.94%)
STATE BANK OF INDIA▲856.00
7.50 (0.88%)
HDFC BANK▼1,603.90
-12.70 (-0.79%)
RELIANCE POWER▲30.22
0.53 (1.79%)
JIO FIN SERVICES LTD▲334.35
5.15 (1.56%)
ZOMATO▲219.51
0.20 (0.09%)
ADANI PORT & SEZ▲1,525.85
38.85 (2.61%)
BHARAT ELECTRONICS▲308.00
6.55 (2.17%)
INDIAN RAILWAY TOURISM CORP▲978.00
8.85 (0.91%)
INDIAN OIL CORP▼176.33
-0.52 (-0.29%)
RATTANINDIA POWER▲16.97
0.16 (0.95%)
MRF▲1,37,751.00
160.90 (0.12%)
ADANI ENTERPRISES▲3,041.75
68.25 (2.30%)
JAIPRAKASH POWER VENTURES▲19.37
0.54 (2.87%)
![stock logo](https://assets.upstox.com/content/assets/images/logos/NSE_EQ|INE0O5T01011.png)
REMUS PHARMACEUTICALS L Share Price
REMUS
₹1,940.00-₹0.35 (-0.02%) TodayLast updated on 26 Jul, 2024 | 11:21 IST
₹1,900.00₹1,943.00
L
H
What’s in news?
Company overview
Financial performance
Market cap
| Open₹1,900.00 | Close₹1,940.35 |
Circuit range₹2,328.40 - ₹1,552.30 | Day range₹1,900.00 - ₹1,943.00 | Year range₹1,785.10 - ₹8,747.00 |
Volume1,900 | Avg. traded₹1,937.11 | Revenue (12m)₹45 Crs |
REMUS PHARMACEUTICALS LRemus Pharmaceuticals Limited is engaged in marketing and distribution of finished formulations of pharmaceutical drugs. The Company also deals in active pharmaceutical ingredient (API). It also provides technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. It deals in drug forms like capsules, cream, eye drops, gel, infusion, inhalation, inhaler, injection, nail lacquer, nasal solution, nasal spray, nebulizer, ointment, ophthalmic, oral gel, oral solution, oral suspension, sachet, suspension, tablet. The therapeutic areas it works include oncology, cardiovascular, anti-diabetic, immune suppressants, anti-biotic, antibacterial, dermatology, central nervous system, and others. Its oncology products include Sorafenib Tablets, Enzalutamide Capsules, Lenalidomide Capsule, and others. Its cardiovascular products include Rivaroxaban Tablets, Ticagrelor Tablets, and others.
REMUS PHARMACEUTICALS L Key indicators
52 week high₹8,747.00 | 52 week low₹1,785.10 | P/E ratio119.61 |
P/B ratio194.04 | ROE66.14% | ROCE68.82% |
Dividend yield0.1% | Debt/Equity ratio0.42 | EPS78.37 |
Learn more
Featured in
Investment checklist: (3/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Fundamentals
Financial ratios
Operating profit margin26.93% | Net profit margin18.88% |
ROE66.14% | ROA33.77% |
ROCE68.82% |
Learn more
REMUS PHARMACEUTICALS L Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Thu, Jul 25 2024 | ₹1,850.00 | ₹1,940.35 | |
Wed, Jul 24 2024 | ₹1,910.00 | ₹1,930.70 | |
Tue, Jul 23 2024 | ₹1,960.00 | ₹1,911.30 | -2.60% |
Mon, Jul 22 2024 | ₹2,024.00 | ₹1,962.35 | |
Fri, Jul 19 2024 | ₹1,925.00 | ₹1,918.55 | -1.39% |
Thu, Jul 18 2024 | ₹1,950.00 | ₹1,945.50 | -0.23% |
Tue, Jul 16 2024 | ₹1,990.00 | ₹1,949.95 | -1.91% |
Mon, Jul 15 2024 | ₹2,125.00 | ₹1,987.90 | -0.49% |
Events
Corporate actions
Bonus • 3:1
Ex date 06 Jun 2024
Dividend • ₹4/share
Ex date 02 May 2024
Dividend • ₹2/share
Ex date 27 Oct 2023
Dividend • ₹2/share
Ex date 15 Sep 2023
Learn more